Alps Advisors Inc. Buys 10,845 Shares of Chemed Corporation $CHE

Alps Advisors Inc. raised its stake in shares of Chemed Corporation (NYSE:CHE) by 32.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 44,295 shares of the company’s stock after purchasing an additional 10,845 shares during the period. Alps Advisors Inc.’s holdings in Chemed were worth $19,833,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Creekmur Asset Management LLC bought a new position in shares of Chemed during the 2nd quarter valued at approximately $28,000. First Horizon Corp purchased a new position in Chemed during the third quarter worth $31,000. Pilgrim Partners Asia Pte Ltd bought a new position in Chemed during the third quarter valued at $45,000. Parkside Financial Bank & Trust increased its position in Chemed by 86.3% during the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after acquiring an additional 44 shares during the last quarter. Finally, HM Payson & Co. raised its stake in shares of Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after acquiring an additional 27 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total value of $875,100.00. Following the transaction, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.29% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CHE shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Jefferies Financial Group cut Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Finally, Royal Bank Of Canada decreased their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $555.50.

Chemed Price Performance

Chemed stock opened at $447.56 on Monday. The stock has a market cap of $6.34 billion, a price-to-earnings ratio of 23.67, a price-to-earnings-growth ratio of 2.18 and a beta of 0.44. The firm has a 50-day moving average of $436.81 and a two-hundred day moving average of $441.79. Chemed Corporation has a 1 year low of $408.42 and a 1 year high of $623.60.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.